-
Tesla shares fall as Musk touts ambitious -- and costly -- plans
-
June heatwave cost UK economy more than £1bn: study
-
Houthis claim Red Sea tanker strikes as US hits Iran again
-
Google-parent Alphabet beats expectations, cloud revenue nearly doubles
-
Wildfires ravage parts of southern France, Italy and Spain
-
US announces civilian nuclear deal with Saudi Arabia
-
Alphabet beats expectations in second quarter, cloud revenue nearly doubles
-
Tesla shares dip after profit misses expectations
-
Trump threatens Iran infrastructure, Tehran vows 'eye for eye'
-
Red Sox tie club record with 15th straight MLB win
-
US teen withdraws lawsuit against Meta over social media addiction
-
US eyes offshore nuclear reactors
-
Lebanon PM says Beirut working for 'complete Israeli withdrawal'
-
The Sterling Announces Luxury Cocktail Lounge Concept and Investor Showcase in Orlando
-
EU conditionally clears Paramount bid for Warner Bros.
-
Inter Miami signs Brazil veteran Casemiro but MLS probes deal
-
Philipsen snaps 'horrible' drought with Tour de France stage 17 victory
-
White House accuses China's Moonshot of stealing Anthropic AI
-
US trial of Venezuela's Maduro set for June 2027
-
Pogacar sweating on Yates's fitness ahead of Tour Queen stage
-
New UK PM Burnham gets early boost as inflation dips
-
Ukrainian soldiers and civilians welcome new army commander
-
Samsung launches new, more expensive foldable smartphones
-
UK fintech Revolut valuation soars to $115 bn: source
-
Philipsen ends 'horrible' drought with Tour de France 17th stage victory
-
German FM, on Africa tour, eyes business ties amid US, China pressure
-
Hungary's Orban says graft case is 'pretext' to target his party
-
Rubio says at ASEAN meeting he expects 'positive' US visit by China's Xi
-
South African tycoon Motsepe rules out presidential bid
-
Philipsen wins Tour de France 17th stage
-
Trump threatens Iran bridges, power as payback for Hormuz attacks
-
DonnaPro Introduces AI-Trained Executive Assistants for European CEOs
-
Germany's Merz replaces leader ousted over surrogacy row
-
Happy birthday, George! UK prince becomes a teenager
-
CAF chief Motsepe backs Infantino despite criticism
-
Oil prices jump on Mideast war, stock markets diverge
-
Evacuees from Spain's wildfire struggle with scale of devastation
-
US hits Iranian island, says war cost at $37.5 bn
-
Ancient Lebanese city of Tyre added to heritage danger list
-
Metal mining's carbon footprint far larger than thought: study
-
Extreme heatwave grips Tunisia as wide power cuts fuel frustration
-
TokenInsight Q2 2026 Report: TradFi Momentum Lifts MEXC to No. 2 in Commodity Perpetuals
-
'Beautiful game' provides Venezuelans with welcome distraction in wake of tragedy
-
Leonardo chief sees potential for Germany to join GCAP fighter jet project
-
Oil prices surge on Mideast war, stock markets diverge
-
Louvre heist gallery reopens to public, but with nothing to steal
-
Fury says 'best yet to come' ahead of Thailand fight
-
Ukraine's new army chief: who is Mykhailo Drapaty?
-
Japan suffers heat 'disaster as cities hit by 'cruelly hot' days
-
India student protests keep up pressure on Modi government
No link between paracetamol and autism, major review finds
There is no clear link between pregnant women taking the common painkiller paracetamol and autism in their children, despite repeated claims otherwise by Donald Trump, according to the most comprehensive review of the existing evidence published Monday.
In September, the US president sparked outrage among the medical community by claiming that paracetamol -- also known as acetaminophen -- was associated with higher rates of autism.
Trump urged pregnant women to "tough it out" rather than take paracetamol, comments which health researchers warned could scare women off their safest option to treat pain -- and risked further stigmatising autistic people.
The World Health Organization has emphasised that there is no robust evidence showing that paracetamol -- which is the main ingredient in massively popular painkillers such as Tylenol and Panadol -- causes autism.
On Monday, an "umbrella" review of all the scientific research yet conducted on the subject was published in the British medical journal BMJ.
"Existing evidence does not show a clear link between in utero exposure to paracetamol and autism and ADHD in offspring," the UK-lead team of researchers wrote in the review.
There have been several previous studies which suggested a possible link between paracetamol and autism or attention deficit hyperactivity disorder (ADHD).
However the quality of those studies was "low to critically low", the review said, partly because they did not take adequate steps to rule out potentially misleading factors such as whether autism runs in the family.
These controversial previous studies also could not establish exactly how paracetamol might cause autism.
The umbrella review called for better research, pointing out that there has been a "historical and ongoing underinvestment in women's health research".
- Confirmation -
Several researchers praised the new study.
Dimitrios Siassakos, professor in obstetrics and gynaecology at University College London, said the review "confirms what experts around the globe have been saying".
"Autistic and neurodivergent people are more likely to experience chronic pain, and they are also much more likely to have neurodivergent children -- but paracetamol doesn't cause neurodivergence," said Steven Kapp of the University of Portsmouth.
"As a researcher and autistic person with ADHD, I think we should not be trying to prevent neurodivergence anyway, but make life better for neurodivergent people," he added.
Beyond paracetamol, Trump and his vaccine-sceptic Health Secretary Robert F. Kennedy Jr have repeatedly made unfounded claims about autism, including that there is an "epidemic" of cases.
However experts maintain that the recent increase in autism rates is due to improved, broadened diagnosis methods along with growing awareness.
C.Stoecklin--VB